Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04740736 · ClinicalTrials.gov registry record · NA

Cardiovascular Analysis of PEM

A NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT04740736 is a NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 106 participants, below the 7,240-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04740736, a NA study of Chronic Fatigue Syndrome and Myalgic Encephalomyelitis, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine cardiopulmonary function in Chronic Fatigue Syndrome (CFS) patients and determine how it relates to the common symptom of Post-exertional malaise (PEM). Subjects will complete a maximal exercise test on 2 subsequent days. Total blood volume will be measured prior to each exercise test, and patient with hypovolemia on day 1, will be randomized to either a saline or sham infusion prior to the 2nd exercise test. A total of 80 CFS patients will be enrolled.

Interventions

  • PROCEDURE Saline Infusion

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2021-08-31
Est. Completion 2025-07-11
Phase NA

What the Registry Record Tells You About NCT04740736

The ClinicalTrials.gov registry entry for NCT04740736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,240-participant average among 14 other Chronic Fatigue Syndrome trials with a reported enrollment target (99% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Saline Infusion is the first listed.

NCT04740736 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04740736 about?

NCT04740736 is a clinical study titled "Cardiovascular Analysis of PEM". The purpose of this study is to examine cardiopulmonary function in Chronic Fatigue Syndrome (CFS) patients and determine how it relates to the common symptom of Post-exertional malaise (PEM). Subjects will complete a maximal exercise test on 2 subsequent days. Total blood volume will be measured pr...

What is the current status of trial NCT04740736?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2021-08-31. Estimated completion is 2025-07-11.

What conditions does trial NCT04740736 study?

This clinical trial studies the following conditions: Chronic Fatigue Syndrome, Myalgic Encephalomyelitis.

What interventions are being tested in trial NCT04740736?

The interventions under investigation include: Saline Infusion (PROCEDURE).

Who is sponsoring clinical trial NCT04740736?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04740736 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Fatigue Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.